Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

ClinicalTrials.gov ID: NCT01839916

Public ClinicalTrials.gov record NCT01839916. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 21, 2026, 12:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pilot Study of Prophylactic Dose-Escalation Donor Lymphocyte Infusion After T Cell Depleted Allogeneic Stem Cell Transplant in High Risk Patients With Hematologic Malignancies

Study identification

NCT ID: NCT01839916
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: University of Chicago; Other
Enrollment: 77 participants

Conditions and interventions

Conditions

Interventions

laboratory biomarker analysis Other
therapeutic allogeneic lymphocytes Biological

Other · Biological

Eligibility (public fields only)

Age range: 14 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 3, 2013
Primary completion: Jul 31, 2018
Completion: Jul 31, 2018
Last update posted: Aug 6, 2019

2013 – 2018

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
University of Chicago Comprehensive Cancer Center	Chicago	Illinois	60637-1470	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01839916, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 6, 2019 · Synced May 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01839916 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →